JPWO2022182763A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022182763A5 JPWO2022182763A5 JP2023550647A JP2023550647A JPWO2022182763A5 JP WO2022182763 A5 JPWO2022182763 A5 JP WO2022182763A5 JP 2023550647 A JP2023550647 A JP 2023550647A JP 2023550647 A JP2023550647 A JP 2023550647A JP WO2022182763 A5 JPWO2022182763 A5 JP WO2022182763A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- treg population
- treg
- engineered
- resting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152787P | 2021-02-23 | 2021-02-23 | |
| US63/152,787 | 2021-02-23 | ||
| PCT/US2022/017526 WO2022182763A1 (en) | 2021-02-23 | 2022-02-23 | Methods for expanding regulatory t cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024507373A JP2024507373A (ja) | 2024-02-19 |
| JP2024507373A5 JP2024507373A5 (https=) | 2025-03-04 |
| JPWO2022182763A5 true JPWO2022182763A5 (https=) | 2025-03-04 |
Family
ID=83048425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550647A Pending JP2024507373A (ja) | 2021-02-23 | 2022-02-23 | 制御性ｔ細胞を増殖させる方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240228962A9 (https=) |
| EP (1) | EP4297757A4 (https=) |
| JP (1) | JP2024507373A (https=) |
| CN (1) | CN116897201A (https=) |
| AU (1) | AU2022226163A1 (https=) |
| CA (1) | CA3206049A1 (https=) |
| WO (1) | WO2022182763A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024243552A1 (en) * | 2023-05-25 | 2024-11-28 | Board Of Regents, The University Of Texas System | Methods using st2 to identify patients for cancer therapy |
| WO2025096685A1 (en) * | 2023-10-30 | 2025-05-08 | City Of Hope | Methods of making and using regulatory t cells for treatment of autoimmune disorders and cancers |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1715889A4 (en) * | 2004-01-08 | 2008-03-05 | Univ California | LYMPHOCYTES T REGULATORS SUPPRESSING AUTOIMMUNITY |
| US20130101567A1 (en) * | 2010-04-08 | 2013-04-25 | The Trustees Of The University Of Pennsylvania | Methods to Expand a T Regulatory Cell Master Cell Bank |
| US9018006B2 (en) * | 2010-07-23 | 2015-04-28 | The University Of Toledo | Stable Tregs and related materials and methods |
| WO2013131045A1 (en) * | 2012-03-02 | 2013-09-06 | The Regents Of The University Of California | Expansion of alloantigen-reactive regulatory t cells |
| WO2014183056A1 (en) * | 2013-05-10 | 2014-11-13 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Design and use of specific regulatory t-cells to induce immune tolerance |
| EP3551749B1 (en) * | 2016-12-07 | 2023-09-27 | East Carolina University | Compositions and methods for in vitro cultivation and/or expansion of regulatory t cells |
| WO2018136566A1 (en) * | 2017-01-18 | 2018-07-26 | F1 Oncology, Inc. | Methods of transducing and expanding immune cells and uses thereof |
| JP7618192B2 (ja) * | 2017-03-28 | 2025-01-21 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 移植された組織を拒絶反応から保護するための方法 |
| US10842815B2 (en) * | 2017-06-16 | 2020-11-24 | Stemspine Llc | Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies |
| JP7387603B2 (ja) * | 2017-11-29 | 2023-11-28 | フィジーン、エルエルシー | 活性化のための線維芽細胞と免疫細胞との相互作用及びそれらの使用 |
| AU2019269601A1 (en) * | 2018-05-17 | 2020-11-26 | Regents Of The University Of Minnesota | Drug-resistant immune cells and methods of use thereof |
| KR20210125509A (ko) * | 2019-02-01 | 2021-10-18 | 케이에스큐 세러퓨틱스 인코포레이티드 | 개선된 면역요법을 위한 유전자-조절 조성물 및 방법 |
-
2022
- 2022-02-23 CN CN202280016734.1A patent/CN116897201A/zh active Pending
- 2022-02-23 CA CA3206049A patent/CA3206049A1/en active Pending
- 2022-02-23 WO PCT/US2022/017526 patent/WO2022182763A1/en not_active Ceased
- 2022-02-23 AU AU2022226163A patent/AU2022226163A1/en active Pending
- 2022-02-23 JP JP2023550647A patent/JP2024507373A/ja active Pending
- 2022-02-23 US US18/547,627 patent/US20240228962A9/en active Pending
- 2022-02-23 EP EP22760340.4A patent/EP4297757A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies | |
| van den Brink et al. | Relapse after allogeneic hematopoietic cell therapy | |
| Ross et al. | Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation | |
| CN103930130B (zh) | 抗第三方中央型记忆t细胞、其产生方法以及其在移植和疾病治疗中的应用 | |
| Dummer et al. | FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance | |
| CN103898051B (zh) | 提高免疫反应性的方法 | |
| Saito et al. | Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1–specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature | |
| US12569516B2 (en) | Subject-specific tumor inhibiting cells and the use thereof | |
| Haase et al. | Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD | |
| JP2021516224A5 (https=) | ||
| Bolton et al. | Avoiding immunological rejection in regenerative medicine | |
| JP2025514745A5 (https=) | ||
| Rezvani et al. | Prevention of graft-vs.-host disease | |
| JP2024511052A (ja) | 濃縮された制御性ｔ細胞の集団及びその産生方法 | |
| Gooptu et al. | Effect of antihuman T lymphocyte globulin on immune recovery after myeloablative allogeneic stem cell transplantation with matched unrelated donors: analysis of immune reconstitution in a double-blind randomized controlled trial | |
| Maurer et al. | The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation | |
| JP2022023136A5 (https=) | ||
| CN114040967A (zh) | 造血干细胞移植后恢复及促进恢复的改进 | |
| Gooptu et al. | Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond | |
| Gao et al. | Induced regulatory T cells modified by knocking down T-bet in combination with ectopic expression of inhibitory cytokines effectively protect graft-versus-host disease | |
| JPWO2022182763A5 (https=) | ||
| US9783616B2 (en) | Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organs | |
| US20240226168A1 (en) | Engineered nk cells and uses thereof | |
| JPWO2022221696A5 (https=) | ||
| JP2019508056A5 (https=) |